- Home
- CDXS vs PKBK Comparison
CDXS vs PKBK Comparison
Compare CDXS & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- PKBK
- Stock Information
- Founded
- CDXS 2002
- PKBK 1999
- Country
- CDXS United States
- PKBK United States
- Employees
- CDXS N/A
- PKBK N/A
- Industry
- CDXS Major Chemicals
- PKBK Major Banks
- Sector
- CDXS Industrials
- PKBK Finance
- Exchange
- CDXS Nasdaq
- PKBK Nasdaq
- Market Cap
- CDXS 201.3M
- PKBK 227.0M
- IPO Year
- CDXS 2010
- PKBK N/A
- Fundamental
- Price
- CDXS $2.27
- PKBK $19.02
- Analyst Decision
- CDXS Buy
- PKBK
- Analyst Count
- CDXS 2
- PKBK 0
- Target Price
- CDXS $11.00
- PKBK N/A
- AVG Volume (30 Days)
- CDXS 1.0M
- PKBK 17.8K
- Earning Date
- CDXS 08-07-2025
- PKBK 07-18-2025
- Dividend Yield
- CDXS N/A
- PKBK 3.75%
- EPS Growth
- CDXS N/A
- PKBK 24.08
- EPS
- CDXS N/A
- PKBK 2.41
- Revenue
- CDXS $49,815,000.00
- PKBK $64,206,999.00
- Revenue This Year
- CDXS $12.77
- PKBK N/A
- Revenue Next Year
- CDXS $22.12
- PKBK N/A
- P/E Ratio
- CDXS N/A
- PKBK $7.92
- Revenue Growth
- CDXS N/A
- PKBK N/A
- 52 Week Low
- CDXS $1.90
- PKBK $15.30
- 52 Week High
- CDXS $6.08
- PKBK $24.29
- Technical
- Relative Strength Index (RSI)
- CDXS 48.16
- PKBK 46.71
- Support Level
- CDXS $2.20
- PKBK $18.78
- Resistance Level
- CDXS $2.51
- PKBK $19.81
- Average True Range (ATR)
- CDXS 0.14
- PKBK 0.38
- MACD
- CDXS -0.00
- PKBK -0.06
- Stochastic Oscillator
- CDXS 42.65
- PKBK 35.92
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.